Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Smear-negative pulmonary tuberculosis

A K Dutt1, W W Stead

  • 1Medical Service, Alvin C. York VA Medical Center, Murfreesboro, TN 37130.

Seminars in Respiratory Infections
|June 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Opportunities for Training in Biomedical Informatics at Vanderbilt University.

Yearbook of medical informatics·2016
Same author

Persistence of a strain of Mycobacterium tuberculosis in a prison system.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2004
Same author

Self injection of organophosphorous insecticide.

The Journal of the Association of Physicians of India·2001
Same author

Variation in vulnerability to tuberculosis in America today: random, or legacies of different ancestral epidemics?

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2001
Same author

Get both the medicine and the informatics right.

Journal of the American Medical Informatics Association : JAMIA·2001
Same author

Recurrent tuberculosis due to exogenous reinfection.

The New England journal of medicine·2001
Same journal

TB vaccines at the turn of the century: insights into immunity to M. tuberculosis and modern approaches for prevention of an ancient disease.

Seminars in respiratory infections·2003
Same journal

Environmental infection control of tuberculosis.

Seminars in respiratory infections·2003
Same journal

Mycobacterium tuberculosis: the treatment of active disease.

Seminars in respiratory infections·2003
Same journal

Pediatric tuberculosis.

Seminars in respiratory infections·2003
Same journal

Clinical and radiographic features of HIV-related tuberculosis.

Seminars in respiratory infections·2003
Same journal

Treatment of latent tuberculosis infection.

Seminars in respiratory infections·2003
See all related articles

Diagnosing tuberculosis can be challenging with negative sputum smears. Shorter treatment regimens are effective for smear-negative tuberculosis patients, including those with positive or negative cultures.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Sputum smears are crucial for tuberculosis diagnosis, but negative results in symptomatic patients pose challenges.
  • Smear-negative tuberculosis patients can have positive cultures or remain culture-negative, complicating treatment decisions.
  • Determining appropriate chemotherapy regimens and durations for smear-negative tuberculosis is critical.

Purpose of the Study:

  • To review treatment strategies for smear-negative tuberculosis.
  • To evaluate the efficacy of different drug regimens and durations for smear-negative cases.

Main Methods:

  • Review of British Medical Research Council (BMRC) studies.
  • Analysis of treatment outcomes in smear-negative/culture-positive and smear-negative/culture-negative tuberculosis patients.

Related Experiment Videos

  • Comparison of treatment regimens including streptomycin (SM), isoniazid (INH), rifampin (RIF), and pyrazinamide (PZA).

    • Main Results:

    • A 4-month intensive treatment with SM, INH, RIF, and PZA was successful for smear-negative/culture-positive tuberculosis.
    • A 6-month regimen of INH and RIF showed good results in Arkansas for smear-negative cases with low primary drug resistance.
    • Four-month treatment with SM, INH, RIF, and PZA (daily or thrice weekly) is effective for smear-negative/culture-negative tuberculosis.

    Conclusions:

    • Shorter treatment durations are feasible for smear-negative tuberculosis.
    • Treatment regimens should be tailored based on culture results and local drug resistance patterns.
    • Effective treatment options exist for smear-negative tuberculosis, simplifying clinical management.